Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7413411
Reference Type
Journal Article
Title
Bioactive Flavonoid Apigenin and Its Nanoformulations: A Promising Hope for Diabetes and Cancer
Author(s)
Mukherjee, B; Banerjee, S; Mondal, L; Chakraborty, S; Chanda, D; Perera, JAC; ,
Year
2020
Publisher
Springer Singapore
Location
Singapore
Book Title
Nanomedicine for Bioactives
Page Numbers
367-382
DOI
10.1007/978-981-15-1664-1_13
URL
http://link.springer.com/10.1007/978-981-15-1664-1_13
Exit
Abstract
Apigenin, an important flavones, belongs to the subclass of flavonoids. Apigenin proved its potency towards different dreadful pathophysiological conditions, including diabetes and cancer which share their risk factors to complement each other and are the major causes of mortality worldwide. Apigenin is found to be effective in different in vitro cellular studies and also in different in vivo systems. It has the protective efficiency to counteract the deregulation of cell cycle at different checkpoints, autophagy, apoptosis and neurodegeneration. The mechanism of action of apigenin so far convinced the scientific world towards its acceptance as an anticancer and antidiabetic agent which also favours the usefulness of apigenin nanoformulations to be used as modern therapeutic tool. However, poor water solubility and non-specificity towards its target tissues have been successfully overcome by using various nanocarriers of apigenin. This chapter will focus on the array of biological activities of apigenin and address the issues of delivering apigenin through nanocarriers to improve the efficacy of apigenin, more particularly in diabetes and various types of cancer.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity